Evaluation of Corneal Endothelial Cell Loss After Uncomplicated Phacoemulsification Cataract Surgery With Intracameral Phenylephrine

Li Sar Teoh, Siu Wan Foo, Vanessa Naseem Mansurali, Ee Ling Ang, Umi Kalthum Md Noh, Mae-Lynn Catherine Bastion

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

PURPOSE: To study the effects of intracameral phenylephrine 1.5% on corneal endothelial cell loss and morphological changes in patients who had uneventful phacoemulsification surgery.

DESIGN: A double-blind randomized controlled trial.

METHODS: This study comprised 295 patients who were randomized into the intracameral (ICM) mydriatic group or topical mydriatic group. Central corneal endothelial cell density (ECD), coefficient of variation (CV), and percentage of hexagonal cells were measured preoperatively and postoperatively at 1 week, 6 weeks, and 3 months with specular microscope.

RESULTS: There was no significant difference in endothelial cell density and endothelial cell loss between the topical and ICM mydriatic groups. At 3 months, the mean endothelial cell density in the ICM group was 2129.76 ± 423.53 cells/mm2 and 2100.54 ± 393.00 cells/mm2 in the topical group (P = 0.539). The endothelial cell loss was 18.60 ± 12.79% in the IC M group and 19.44 ± 11.24% in the topical group (P = 0.550). No significant difference was seen in the percentage of hexagonal cells and coefficient of variation of patients between the 2 groups.

CONCLUSIONS: Intracameral phenylephrine was not associated with increased risk of postoperative endothelial cell loss or morphological changes. It can be safely injected into the anterior chamber for pupil dilatation before phacoemulsification cataract surgery.

Original languageEnglish
Pages (from-to)318-325
Number of pages8
JournalAsia-Pacific journal of ophthalmology (Philadelphia, Pa.)
Volume6
Issue number4
DOIs
Publication statusPublished - 1 Jul 2017

Fingerprint

Corneal Endothelial Cell Loss
Phacoemulsification
Phenylephrine
Cataract
Endothelial Cells
Mydriatics
Cell Count
Anterior Chamber
Pupil
Dilatation
Randomized Controlled Trials

Keywords

  • corneal endothelial cell
  • intracameral phenylephrine
  • mydriatics

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Evaluation of Corneal Endothelial Cell Loss After Uncomplicated Phacoemulsification Cataract Surgery With Intracameral Phenylephrine. / Teoh, Li Sar; Foo, Siu Wan; Mansurali, Vanessa Naseem; Ang, Ee Ling; Md Noh, Umi Kalthum; Bastion, Mae-Lynn Catherine.

In: Asia-Pacific journal of ophthalmology (Philadelphia, Pa.), Vol. 6, No. 4, 01.07.2017, p. 318-325.

Research output: Contribution to journalArticle

@article{cfbeb52f7c1a45b484cb1583cf3e6e4b,
title = "Evaluation of Corneal Endothelial Cell Loss After Uncomplicated Phacoemulsification Cataract Surgery With Intracameral Phenylephrine",
abstract = "PURPOSE: To study the effects of intracameral phenylephrine 1.5{\%} on corneal endothelial cell loss and morphological changes in patients who had uneventful phacoemulsification surgery.DESIGN: A double-blind randomized controlled trial.METHODS: This study comprised 295 patients who were randomized into the intracameral (ICM) mydriatic group or topical mydriatic group. Central corneal endothelial cell density (ECD), coefficient of variation (CV), and percentage of hexagonal cells were measured preoperatively and postoperatively at 1 week, 6 weeks, and 3 months with specular microscope.RESULTS: There was no significant difference in endothelial cell density and endothelial cell loss between the topical and ICM mydriatic groups. At 3 months, the mean endothelial cell density in the ICM group was 2129.76 ± 423.53 cells/mm2 and 2100.54 ± 393.00 cells/mm2 in the topical group (P = 0.539). The endothelial cell loss was 18.60 ± 12.79{\%} in the IC M group and 19.44 ± 11.24{\%} in the topical group (P = 0.550). No significant difference was seen in the percentage of hexagonal cells and coefficient of variation of patients between the 2 groups.CONCLUSIONS: Intracameral phenylephrine was not associated with increased risk of postoperative endothelial cell loss or morphological changes. It can be safely injected into the anterior chamber for pupil dilatation before phacoemulsification cataract surgery.",
keywords = "corneal endothelial cell, intracameral phenylephrine, mydriatics",
author = "Teoh, {Li Sar} and Foo, {Siu Wan} and Mansurali, {Vanessa Naseem} and Ang, {Ee Ling} and {Md Noh}, {Umi Kalthum} and Bastion, {Mae-Lynn Catherine}",
year = "2017",
month = "7",
day = "1",
doi = "10.22608/APO.2016206",
language = "English",
volume = "6",
pages = "318--325",
journal = "Asia-Pacific Journal of Ophthalmology",
issn = "2162-0989",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Evaluation of Corneal Endothelial Cell Loss After Uncomplicated Phacoemulsification Cataract Surgery With Intracameral Phenylephrine

AU - Teoh, Li Sar

AU - Foo, Siu Wan

AU - Mansurali, Vanessa Naseem

AU - Ang, Ee Ling

AU - Md Noh, Umi Kalthum

AU - Bastion, Mae-Lynn Catherine

PY - 2017/7/1

Y1 - 2017/7/1

N2 - PURPOSE: To study the effects of intracameral phenylephrine 1.5% on corneal endothelial cell loss and morphological changes in patients who had uneventful phacoemulsification surgery.DESIGN: A double-blind randomized controlled trial.METHODS: This study comprised 295 patients who were randomized into the intracameral (ICM) mydriatic group or topical mydriatic group. Central corneal endothelial cell density (ECD), coefficient of variation (CV), and percentage of hexagonal cells were measured preoperatively and postoperatively at 1 week, 6 weeks, and 3 months with specular microscope.RESULTS: There was no significant difference in endothelial cell density and endothelial cell loss between the topical and ICM mydriatic groups. At 3 months, the mean endothelial cell density in the ICM group was 2129.76 ± 423.53 cells/mm2 and 2100.54 ± 393.00 cells/mm2 in the topical group (P = 0.539). The endothelial cell loss was 18.60 ± 12.79% in the IC M group and 19.44 ± 11.24% in the topical group (P = 0.550). No significant difference was seen in the percentage of hexagonal cells and coefficient of variation of patients between the 2 groups.CONCLUSIONS: Intracameral phenylephrine was not associated with increased risk of postoperative endothelial cell loss or morphological changes. It can be safely injected into the anterior chamber for pupil dilatation before phacoemulsification cataract surgery.

AB - PURPOSE: To study the effects of intracameral phenylephrine 1.5% on corneal endothelial cell loss and morphological changes in patients who had uneventful phacoemulsification surgery.DESIGN: A double-blind randomized controlled trial.METHODS: This study comprised 295 patients who were randomized into the intracameral (ICM) mydriatic group or topical mydriatic group. Central corneal endothelial cell density (ECD), coefficient of variation (CV), and percentage of hexagonal cells were measured preoperatively and postoperatively at 1 week, 6 weeks, and 3 months with specular microscope.RESULTS: There was no significant difference in endothelial cell density and endothelial cell loss between the topical and ICM mydriatic groups. At 3 months, the mean endothelial cell density in the ICM group was 2129.76 ± 423.53 cells/mm2 and 2100.54 ± 393.00 cells/mm2 in the topical group (P = 0.539). The endothelial cell loss was 18.60 ± 12.79% in the IC M group and 19.44 ± 11.24% in the topical group (P = 0.550). No significant difference was seen in the percentage of hexagonal cells and coefficient of variation of patients between the 2 groups.CONCLUSIONS: Intracameral phenylephrine was not associated with increased risk of postoperative endothelial cell loss or morphological changes. It can be safely injected into the anterior chamber for pupil dilatation before phacoemulsification cataract surgery.

KW - corneal endothelial cell

KW - intracameral phenylephrine

KW - mydriatics

UR - http://www.scopus.com/inward/record.url?scp=85032640268&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032640268&partnerID=8YFLogxK

U2 - 10.22608/APO.2016206

DO - 10.22608/APO.2016206

M3 - Article

VL - 6

SP - 318

EP - 325

JO - Asia-Pacific Journal of Ophthalmology

JF - Asia-Pacific Journal of Ophthalmology

SN - 2162-0989

IS - 4

ER -